Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Return on Assets: 2023-2025

Historic Return on Assets for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to 0.60%.

  • InMed Pharmaceuticals' Return on Assets rose 4.00% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year increase of 4.00%. This contributed to the annual value of 0.60% for FY2025, which is 0.00% changed from last year.
  • InMed Pharmaceuticals' Return on Assets amounted to 0.60% in FY2025, which was down 0.62% from 0.59% recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Return on Assets peaked at 0.59% during FY2023, and registered a low of 0.60% during FY2025.
  • Its 3-year average for Return on Assets is 0.59%, with a median of 0.59% in 2024.
  • The largest annual percentage gain for InMed Pharmaceuticals' Return on Assets in the last 5 years was 0bps (2024), contrasted with its biggest fall of 0bps (2024).
  • Over the past 3 years, InMed Pharmaceuticals' Return on Assets (MRY) stood at 0.59% in 2023, then dropped by 0bps to 0.59% in 2024, then dropped by 1bps to 0.60% in 2025.
  • Its last three reported values are 0.60% in FY2025, 0.59% for FY2024, and 0.59% during FY2023.